About this data
What it is
ClinicalTrials.gov is the US registry of clinical studies. Drug and device makers register their trials there and update the record as each study moves on. We list the studies that companies sponsor, and match the sponsor to a public company when the name lines up. The page opens on Phase 3 studies marked completed, the late-stage trials that come before a request for approval. Change View to see the changes of status we have noticed, or every recent update.
Who files it
The sponsor of the study, in its record on ClinicalTrials.gov. The registry is run by the US National Library of Medicine and does not check what sponsors report.
How current
We check the registry every day. Sponsors update records on their own schedule, from the same week to months later, so a change can appear in the registry well after it happened.
Terms
ClinicalTrials.govClinicalTrials.gov is the US government's registry of clinical studies, run by the National Library of Medicine. Sponsors register a study before it starts and update the record as it goes. The registry does not check what a sponsor reports.Phase 3The late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.statusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).completedThe sponsor has marked the study as finished. It says nothing about whether the treatment worked: results, if any, are reported separately and often later.status changesOur history of status changes starts the day we first stored each study, so a change made before that is not shown. The date is when we noticed the change, which can be later than when the sponsor made it.primary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.company matchWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.
Worth knowing
A completed study is not a result: the registry says the study ended, not whether the treatment worked. Status changes start on the day we first stored each study, so earlier changes are not shown. Dates are the sponsor's own, and an estimated date can pass without an update. We match sponsors to companies automatically, with a hand-checked list for the large drugmakers, so a study with no ticker may still belong to a public company. This is information about studies, not a forecast of what they will show or of a stock's price.
Not to be confused with
FDA approvals and clearances: what the FDA decided, not what a sponsor reports about a study.

All of this comes from ClinicalTrials.gov, the US registry of clinical studies. We are not affiliated with it.

Studies updated per day, last 30 days

0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0
0200400600Oct 17 · All industry-sponsored studies: 0Oct 17 · Sponsor matched to a public company: 0Oct 17Oct 18 · All industry-sponsored studies: 0Oct 18 · Sponsor matched to a public company: 0Oct 19 · All industry-sponsored studies: 238Oct 19 · Sponsor matched to a public company: 79Oct 20 · All industry-sponsored studies: 278Oct 20 · Sponsor matched to a public company: 92Oct 21 · All industry-sponsored studies: 244Oct 21 · Sponsor matched to a public company: 78Oct 21Oct 22 · All industry-sponsored studies: 234Oct 22 · Sponsor matched to a public company: 67Oct 23 · All industry-sponsored studies: 259Oct 23 · Sponsor matched to a public company: 93Oct 24 · All industry-sponsored studies: 0Oct 24 · Sponsor matched to a public company: 0Oct 25 · All industry-sponsored studies: 0Oct 25 · Sponsor matched to a public company: 0Oct 25Oct 26 · All industry-sponsored studies: 253Oct 26 · Sponsor matched to a public company: 70Oct 27 · All industry-sponsored studies: 283Oct 27 · Sponsor matched to a public company: 102Oct 28 · All industry-sponsored studies: 287Oct 28 · Sponsor matched to a public company: 97Oct 29 · All industry-sponsored studies: 256Oct 29 · Sponsor matched to a public company: 88Oct 29Oct 30 · All industry-sponsored studies: 252Oct 30 · Sponsor matched to a public company: 103Oct 31 · All industry-sponsored studies: 0Oct 31 · Sponsor matched to a public company: 0Nov 1 · All industry-sponsored studies: 0Nov 1 · Sponsor matched to a public company: 0Nov 2 · All industry-sponsored studies: 305Nov 2 · Sponsor matched to a public company: 99Nov 2Nov 3 · All industry-sponsored studies: 478Nov 3 · Sponsor matched to a public company: 257Nov 4 · All industry-sponsored studies: 390Nov 4 · Sponsor matched to a public company: 184Nov 5 · All industry-sponsored studies: 356Nov 5 · Sponsor matched to a public company: 143Nov 6 · All industry-sponsored studies: 338Nov 6 · Sponsor matched to a public company: 135Nov 6Nov 7 · All industry-sponsored studies: 0Nov 7 · Sponsor matched to a public company: 0Nov 8 · All industry-sponsored studies: 0Nov 8 · Sponsor matched to a public company: 0Nov 9 · All industry-sponsored studies: 309Nov 9 · Sponsor matched to a public company: 101Nov 10 · All industry-sponsored studies: 347Nov 10 · Sponsor matched to a public company: 139Nov 10Nov 11 · All industry-sponsored studies: 0Nov 11 · Sponsor matched to a public company: 0Nov 12 · All industry-sponsored studies: 576Nov 12 · Sponsor matched to a public company: 214Nov 13 · All industry-sponsored studies: 329Nov 13 · Sponsor matched to a public company: 136Nov 14 · All industry-sponsored studies: 0Nov 14 · Sponsor matched to a public company: 0Nov 14Nov 15 · All industry-sponsored studies: 0Nov 15 · Sponsor matched to a public company: 0

All industry-sponsored studies Sponsor matched to a public company

By the day the sponsor last updated the study's record. A study updated twice counts once, on its latest day.

Latest clinical trial updates

Reset

Showing: ticker SVA · All recent updates

Studies by the date their record was last updated.

Latest clinical trial updates
UpdatedStudySponsorWe match the sponsor's name to a public company automatically, and by hand for the large drugmakers. A subsidiary or a differently spelled name can be missed, so a study with no ticker does not mean the sponsor is private.PhaseThe late stage of testing, usually with hundreds or thousands of people, to confirm that a treatment works and to find side effects. A study marked Phase 2/3 covers both stages.StatusThe registry's own word for where a study stands: not yet recruiting, recruiting, active but not recruiting, completed, terminated (stopped early), withdrawn (never started), suspended, or unknown (the sponsor has not confirmed the record for a long time).EnrolledPrimary completionThe date the last participant is examined for the main question the study asks. The study can run on after it, for follow-up. Sponsors enter the date and revise it, and an estimated date can pass without an update.Source
Nov 10, 2026Influenza Vaccine (Split Virion), Inactivated, Quadrivalent in Pregnant Women
NCT07211152 · Influenza
Participants will receive one dose of vaccine (0.5 mL) of S…
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed150Jun 26, 2026Registry ↗
Oct 22, 2026Study on the Long-Term Persistence of Immunity Induced by Inactivated Hepatitis A Vaccine
NCT07889219 · Hepatitis A
Healive®, Havrix®
SVA
Sinovac Biotech Co., Ltd
—Recruiting106Nov 30, 2026Registry ↗
Oct 22, 2026Phase I Clinical Trial of Trivalent Inactivated Split Influenza Virus Vaccine (MDCK Cell)
NCT07889193 · Seasonal Influenza
Cell-based Trivalent Split Influenza Virus Vaccine (cTIV),…
SVA
Sinovac Biotech Co., Ltd
Phase 1Not yet recruiting175Dec 2026Registry ↗
Oct 2, 2026A Study to Evaluate the 17-Year Immune Persistence of a Single Dose of Inactivated Hepatitis A Vacc…
NCT07855705 · Hepatitis A
Inactivated HAV vaccine, Attenuated live HAV vaccine
SVA
Sinovac Biotech Co., Ltd
—Completed105Mar 9, 2026Registry ↗
Sep 23, 2026Phase I Clinical Trial of Influenza Vaccine (Split Virion), Inactivated (High Dose)
NCT07737106 · Influenza
Influenza Vaccine (Split Virion), Inactivated (High Dose),…
SVA
Sinovac Biotech Co., Ltd
Phase 1Completed50Sep 18, 2025Registry ↗
Sep 21, 2026A Phase IV Clinical Trial of Influenza Vaccine (Split Virion), Inactivatedin (Anflu®) Pregnant Wome…
NCT07832201 · Influenza
Anflu®, Vaxigrip®
SVA
Sinovac Biotech Co., Ltd
Phase 4Not yet recruiting150Feb 2027Registry ↗
Sep 1, 2026Bridging Clinical Trial of EV71 Vaccine in Vietnamese Children
NCT07793175 · Hand, Foot, and Mouth Disease (HFMD), Enterovirus 71 Infect…
EV71 vaccine
SVA
Sinovac Biotech Co., Ltd
Not applicableNot yet recruiting320Jan 9, 2027Registry ↗
Aug 28, 2026Phase Ⅲ Clinical Trial of an Inactivated Hepatitis A Vaccine
NCT07793227 · Hepatitis A Vaccine
Inactivated Hepatitis A Vaccine (Human Diploid Cell) (1 mL)…
SVA
Sinovac Biotech Co., Ltd
Phase 3Recruiting680Sep 15, 2027Registry ↗
Aug 10, 2026Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 2-6 Years
NCT07505888 · Epidemic Meningitis, Meningococcal Vaccines
experimental vaccine, active comparator vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Active, not recruiting660Nov 2026Registry ↗
Aug 10, 2026Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 12-23 Months
NCT07505836 · Epidemic Meningitis, Meningococcal Vaccines
experimental vaccine, Active Comparator vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Recruiting1,040Jan 2027Registry ↗
Aug 10, 2026Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 6-11 Months
NCT07505823 · Epidemic Meningitis, Meningococcal Vaccines
experimental vaccine, Active Comparator vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Recruiting1,040Apr 2027Registry ↗
Aug 10, 2026Phase Ⅲ Trial of Group ACYW135 Meningococcal Conjugate Vaccine in Children Aged 3-5 Months
NCT07505810 · Epidemic Meningitis, Meningococcal Vaccines
experimental vaccine, Active Comparator vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Recruiting880Apr 2027Registry ↗
Jun 26, 2026Inactivated Bivalent Enterovirus Vaccine (Vero Cell) Phase I/II Clinical Trial
NCT06063057 · Hand, Foot and Mouth Disease, Herpangina
low dose Bivalent Enterovirus Vaccine (Vero Cell), Inactiva…
SVA
Sinovac Biotech Co., Ltd
Phase 1/2Completed744Dec 19, 2025Registry ↗
May 28, 2026Protective Efficacy , Immunogenicity and Safety of the Tetravalent Inactivated Enterovirus Vaccine…
NCT07611513 · Hand, Foot, and Mouth Disease(HFMD), Herpangina
Tetravalent Inactivated Enterovirus Vaccine (Vero Cell), Pl…
SVA
Sinovac Biotech Co., Ltd
Phase 3Not yet recruiting6,000Dec 2027Registry ↗
Mar 9, 2026Phase IV Clinical Study of Sequential Vaccination of Sabin Strain and Wild Strain Inactivated Polio…
NCT07457060 · Poliomyelitis
2wIPV+1sIPV, 1wIPV+2sIPV
SVA
Sinovac Biotech Co., Ltd
Phase 4Recruiting480Sep 8, 2026Registry ↗
Mar 4, 2026Tolerability, Safety, and Immunogenicity of Tetravalent Inactivated Enterovirus Vaccine (Vero Cell).
NCT06754384 · Hand, Foot, and Mouth Disease (HFMD), Herpangina
Low-dose of tetravalent inactivated enterovirus vaccine (Ve…
SVA
Sinovac Biotech Co., Ltd
Phase 1/2Completed552Dec 30, 2025Registry ↗
Feb 18, 2026Study to Evaluate the Safety of a Lyophilized RSV mRNA Vaccine
NCT07418229 · RSV, mRNA Vaccine
Low-dose RSV mRNA vaccine, High-dose RSV mRNA vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 1Not yet recruiting60Jun 30, 2026Registry ↗
Feb 17, 2026Phase IIIb Clinical Trial to Evaluate Lot-to-lot Consistency of Sinovac Rabies Vaccine
NCT07416110 · Rabies (Healthy Volunteers)
Sinovac rabies vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Not yet recruiting912Sep 30, 2026Registry ↗
Feb 10, 2026Study to Evaluate the Safety and Immunogenicity of a Lyophilized Herpes Zoster Virus mRNA Vaccine
NCT07400003 · Herpes Zoster, mRNA Vaccine
Low-dose experimental vaccine, High-dose experimental vacci…
SVA
Sinovac Biotech Co., Ltd
Phase 1/2Recruiting519May 31, 2026Registry ↗
Jan 22, 2026Immunogenicity and Safety Assessment of Rabies Vaccine (Vero Cell) for Human Use, Freeze-dried
NCT07357545 · Rabies (Healthy Volunteers)
Sinovac rabies vaccine, Marketed rabies vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed2,040Sep 21, 2022Registry ↗
Jan 21, 2026Phase IV Clinical Study of sIPV Administration in Adolescent and Adult Populations
NCT07354269 · Poliomyelitis
sIPV, DTaP-IPV-Hib
SVA
Sinovac Biotech Co., Ltd
Phase 4Recruiting180Apr 11, 2026Registry ↗
Jan 16, 2026Booster Dose of sIPV Co-administered With MMR and HepA-I.
NCT06442449 · Poliomyelitis
sIPV, MMR
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed889Sep 10, 2025Registry ↗
Dec 18, 2025A Multi-center, Open-labelled, Randomized, Controlled, Extended Phase Ⅲ Clinical Trial of sIPV Vacc…
NCT05850364 · Poliomyelitis, Polio
Sabin Strain Inactivated Poliovirus Vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed1,442Feb 13, 2025Registry ↗
Aug 14, 2025A Phase III Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
NCT06049927 · Seasonal Influenza
Quadrivalent influenza vaccine(0.25ml), Quadrivalent influe…
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed3,300May 23, 2024Registry ↗
Jul 17, 2025A Clinical Trial to Observe the Safety of 23-Valent Pneumococcal Polysaccharide Vaccine in Target P…
NCT07071701 · Pneumococcal Infectious Disease
23-valent pneumococcal polysaccharide vaccine, Influenza va…
SVA
Sinovac Biotech Co., Ltd
—Completed19,267Apr 5, 2024Registry ↗
Jul 9, 2025Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Simulated Post-exposure Pro…
NCT07055893 · Rabies (Healthy Volunteers)
Rabies vaccine, Verorab®
SVA
Sinovac Biotech Co., Ltd
Phase 3Not yet recruiting390Jan 30, 2027Registry ↗
Jul 9, 2025Immunogenicity and Safety of Different Dosages of Rabies Vaccine (Serum-free Vero Cell)
NCT07055880 · Rabies
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verora…
SVA
Sinovac Biotech Co., Ltd
Phase 2Not yet recruiting120Jan 15, 2026Registry ↗
Jul 8, 2025Immunogenicity and Safety of Rabies Vaccine (Serum-free Vero Cell) in a Pre-exposure Prophylaxis Re…
NCT07055295 · Rabies
Rabies Vaccine (Serum-free Vero Cell), Freeze-dried, Verora…
SVA
Sinovac Biotech Co., Ltd
Phase 3Not yet recruiting390Dec 30, 2026Registry ↗
Jun 18, 2025Clinical Trial for Batch Consistency of EV71 Vaccine
NCT07026500 · EV71 Vaccine
EV71 Vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed720Apr 30, 2020Registry ↗
Mar 14, 2025Sequential Vaccination of Poliomyelitis Vaccine (Vero Cells), Inactivated, Sabin Strains From Diffe…
NCT06346834 · Poliomyelitis
sIPV
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed200Sep 6, 2024Registry ↗
Jan 1, 2025Efficacy, Safety, and Immunogenicity of the Bivalent Inactivated Enterovirus Vaccine (Vero Cell)
NCT06734832 · Hand, Foot, and Mouth Disease(HFMD)
bivalent enterovirus vaccine (Vero cell), inactivated, Ente…
SVA
Sinovac Biotech Co., Ltd
Phase 3Recruiting8,000Nov 30, 2025Registry ↗
Aug 21, 2024Immunogenicity and Safety of Hepatitis A Among People Aged 18-50 Years Old
NCT06058416 · Hepatitis A
Healive (hepatitis A vacine(human diploid cell), inactivate…
SVA
Sinovac Biotech Co., Ltd
Phase 4Active, not recruiting1,092Mar 17, 2028Registry ↗
May 28, 2024Immunogenicity and Safety Study of Influenza Vaccine (Split Virion), Inactivated, Quadrivalent
NCT05431725 · Seasonal Influenza
Influenza Vaccine (Split Virion), Inactivated, Quadrivalent…
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed2,202Jul 19, 2023Registry ↗
May 28, 2024A Clinical Trial of Quadrivalent Influenza Vaccine in Healthy Subjects Aged 6 to 35 Months
NCT05245552 · Seasonal Influenza
Quadrivalent influenza vaccine(0.25ml), Quadrivalent influe…
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed217Aug 4, 2023Registry ↗
Apr 15, 2024Safety of Sabin Inactivated Poliovirus Vaccine in Adults, Children and Infants and Lot Consistency…
NCT05386810 · Poliomyelitis
Experimental vaccine, IPV control vaccine
SVA
Sinovac Biotech Co., Ltd
Phase 3Completed1,572Oct 8, 2022Registry ↗
Feb 9, 2024Active Case Finding of Clinical Hand Foot Mouth Disease in Children Aged 6 Months Old to 18 Years O…
NCT06251219 · Hand, Foot and Mouth Disease
PCR
SVA
Sinovac Biotech Co., Ltd
—Unknown100Jun 30, 2025Registry ↗
Jan 17, 2024The Immunogenicity and Safety of the Booster Doses of a Live-attenuated Mumps Vaccine in Junior Hig…
NCT06208683 · Mumps, Influenza
Mumps vaccine, Live (MV), Influenza Vaccine, inactivated, q…
SVA
Sinovac Biotech Co., Ltd
Phase 4Unknown400Feb 2, 2024Registry ↗
Oct 31, 2023A Serosurvey Study of Hand, Foot, and Mouth Disease in Indonesia
NCT05637229 · Hand, Foot and Mouth Disease
SVA
Sinovac Biotech Co., Ltd
—Completed600Dec 19, 2022Registry ↗
Oct 26, 2023Immunogenicity of After Primary Immunization and Booster Immunization of sIPV
NCT06058429 · Polio
no intervention
SVA
Sinovac Biotech Co., Ltd
—Unknown233Sep 7, 2023Registry ↗
Sep 18, 2023Lot-to-lot Consistency of 23-valent Pneumococcal Polysaccharide Vaccine
NCT05731115 · Pneumococcal Infections
Experimental 23-valent Pneumococcal
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed1,800May 5, 2023Registry ↗
Sep 18, 2023Lot-to-lot Consistency of Quadrivalent Influenza Vaccine (Split Virion), Inactivated
NCT05512494 · Seasonal Influenza
Quadrivalent Influenza Vaccine (Split Virion), inactivated
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed1,260Jan 24, 2023Registry ↗
Sep 18, 2023Immunogenicity and Safety of 23-valent Pneumococcal Polysaccharide Vaccine
NCT05477693 · Pneumococcal Infections
Experimental 23-valent PPV, Control 23-valent PPV
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed1,800Apr 10, 2023Registry ↗
Jan 12, 2023A Safety Study of Sabin Inactivated Poliovirus Vaccine in Infants
NCT05432141 · Poliomyelitis
sIPV vaccine /DTaP vaccine, sIPV vaccine /Hepatitis A inact…
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed3,200Sep 13, 2022Registry ↗
Jan 12, 2023An Immunity Persistence Study of Sabin Inactivated Poliovirus Vaccine(Vero Cell) After Four Doses
NCT04989231 · Poliomyelitis
Investigational sIPV, Control IPV
SVA
Sinovac Biotech Co., Ltd
—Completed450Dec 25, 2022Registry ↗
Aug 12, 2022A Study of Booster Immunization With COVID-19 Vaccine,Inactivated Co -Administration With Influenza…
NCT05499351 · COVID-19
Adult group in immunogenicity and safety study of combined…
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed3,000Dec 5, 2021Registry ↗
Aug 12, 2022A Clinical Trial of 23-valent Pneumococcal Polysaccharide Vaccine
NCT04989465 · Pneumococcal Infections
Investigational 23-valent PPV, Control 23-valent PPV
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed600Sep 13, 2021Registry ↗
Aug 11, 2022Immunogenicity And Safety of COVID-19 Vaccine , Inactivated Co -Administration With EV71 Vaccine (V…
NCT05107557 · COVID-19
Experimental Group
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed520Dec 5, 2021Registry ↗
Aug 11, 2022A Clinical Trial of Quadrivalent Influenza Vaccine in Children Aged 3-8 Years Old
NCT04997239 · Seasonal Influenza
Two doses of quadrivalent influenza vaccine, One dose of qu…
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed600Oct 30, 2021Registry ↗
Jul 25, 2022Study on Combined Vaccination With Quadrivalent Influenza Vaccine and 23-valent Pneumococcal Polysa…
NCT05471531 · Influenza and Pneumonia
Combined vaccination with quadrivalent influenza vaccine an…
SVA
Sinovac Biotech Co., Ltd
Phase 4Completed3,000Mar 10, 2022Registry ↗
Jul 11, 2022Safety Observation of Enterovirus 71 Inactivated Vaccine (Vero Cell) Combined Immunization in Shang…
NCT05166044 · Hand, Foot and Mouth Disease
EV71 Inactivated Vaccine
SVA
Sinovac Biotech Co., Ltd
—Unknown12,500Jun 4, 2022Registry ↗

The newest 50 items, most recent first. Each row links to the study's page on ClinicalTrials.gov. Updated Nov 15, 2026, 9:27 PM EST.

Download CSV The rows of this feed, with the filters above. A download holds at most 10,000 rows; narrow the filters to get a smaller slice.

Other feeds: Congressional trades · Executive-branch trades · Bills in Congress · Roll-call votes · Corporate PAC donations · Lobbying · Capitol Hires · Lobbying and contracts · Government contracts · Insider trades · Planned insider sales · Executive pay · Ownership stakes (13D / 13G) · Institutional holdings (13F) · Short interest · Fails to deliver · Daily short volume · Wikipedia page views · App store ratings · H-1B visa applications · Stock splits · 8-K events · IPO filings · Deals · Private placements (Form D) · Merger clearances (HSR) · Layoff notices (WARN) · SEC enforcement · Patents · FDA approvals and clearances